_id
6910500dccc777a4e85d53db
Ticker
CLPT
Name
Clearpoint Neuro Inc
Exchange
NASDAQ
Address
120 S. Sierra Avenue, Solana Beach, CA, United States, 92075
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.clearpointneuro.com
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Last Close
12.71
Volume
166405
Current Price
12.38
Change
-2.596380802517703
Last Updated
2025-11-29T11:33:56.279Z
Image
data:image/webp;base64,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
Ipo Date
2020-02-12T00:00:00.000Z
Market Cap
430160544
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.994
Sentiment Sources
1
Rating
5
Target Price
29
Strong Buy
2
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
8861000
Cost Of Revenue
3261000
Gross Profit
5600000
Operating Expenses
10876000
Operating Income
-5276000
Interest Expense
543000
Pretax Income
-5883000
Net Income
-5891000
Eps
-0.20722837622373264
Dividends Per Share
-
Shares Outstanding
29748308
Income Tax Expense
8000
EBITDA
-5274000
Operating Margin
-59.54181243651958
Total Other Income Expense Net
-607000
Cash
38221000
Short Term Investments
-
Receivables
5256000
Inventories
6583000
Total Current Assets
51329000
Property Plant Equipment
8069000
Total Assets
60357000
Payables
723000
Short Term Debt
347000
Long Term Debt
29203000
Total Liabilities
44483000
Equity
15874000
Depreciation
465000
Change In Working Capital
-1235000
Cash From Operations
-3121000
Capital Expenditures
199000
Cash From Investing
-199000
Cash From Financing
0
Net Change In Cash
-3320000
PE
-
PB
22.761400122212425
ROE
-37.110999118054686
ROA
-9.76025978759713
FCF
-3320000
Fcf Percent
-0.37467554452093443
Piotroski FScore
1
Health Score
13
Deep Value Investing Score
1.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
1
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
8861000
Quarters > 0 > income Statement > cost Of Revenue
3261000
Quarters > 0 > income Statement > gross Profit
5600000
Quarters > 0 > income Statement > operating Expenses
10876000
Quarters > 0 > income Statement > operating Income
-5276000
Quarters > 0 > income Statement > interest Expense
543000
Quarters > 0 > income Statement > pretax Income
-5883000
Quarters > 0 > income Statement > net Income
-5891000
Quarters > 0 > income Statement > eps
-0.20722837622373264
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
28427574
Quarters > 0 > income Statement > income Tax Expense
8000
Quarters > 0 > income Statement > EBITDA
-5274000
Quarters > 0 > income Statement > operating Margin
-59.54181243651958
Quarters > 0 > income Statement > total Other Income Expense Net
-607000
Quarters > 0 > balance Sheet > cash
38221000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
5256000
Quarters > 0 > balance Sheet > inventories
6583000
Quarters > 0 > balance Sheet > total Current Assets
51329000
Quarters > 0 > balance Sheet > property Plant Equipment
8069000
Quarters > 0 > balance Sheet > total Assets
60357000
Quarters > 0 > balance Sheet > payables
723000
Quarters > 0 > balance Sheet > short Term Debt
347000
Quarters > 0 > balance Sheet > long Term Debt
29203000
Quarters > 0 > balance Sheet > total Liabilities
44483000
Quarters > 0 > balance Sheet > equity
15874000
Quarters > 0 > cash Flow > net Income
-5891000
Quarters > 0 > cash Flow > depreciation
465000
Quarters > 0 > cash Flow > change In Working Capital
-1235000
Quarters > 0 > cash Flow > cash From Operations
-3121000
Quarters > 0 > cash Flow > capital Expenditures
199000
Quarters > 0 > cash Flow > cash From Investing
-199000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-3320000
Quarters > 0 > ratios > PE
-0.20722837622373264
Quarters > 0 > ratios > PB
22.761400122212425
Quarters > 0 > ratios > ROE
-37.110999118054686
Quarters > 0 > ratios > ROA
-9.76025978759713
Quarters > 0 > ratios > FCF
-3320000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.37467554452093443
Quarters > 0 > health Score
13
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
9215000
Quarters > 1 > income Statement > cost Of Revenue
3659000
Quarters > 1 > income Statement > gross Profit
5556000
Quarters > 1 > income Statement > operating Expenses
11236000
Quarters > 1 > income Statement > operating Income
-5680000
Quarters > 1 > income Statement > interest Expense
80000
Quarters > 1 > income Statement > pretax Income
-5812000
Quarters > 1 > income Statement > net Income
-5837000
Quarters > 1 > income Statement > eps
-0.20655874441159863
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
28258305
Quarters > 1 > income Statement > income Tax Expense
25000
Quarters > 1 > income Statement > EBITDA
-5106000
Quarters > 1 > income Statement > operating Margin
-61.63863266413456
Quarters > 1 > income Statement > total Other Income Expense Net
-132000
Quarters > 1 > balance Sheet > cash
41541000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
4260000
Quarters > 1 > balance Sheet > inventories
6293000
Quarters > 1 > balance Sheet > total Current Assets
53991000
Quarters > 1 > balance Sheet > property Plant Equipment
8158000
Quarters > 1 > balance Sheet > total Assets
62869000
Quarters > 1 > balance Sheet > payables
1531000
Quarters > 1 > balance Sheet > short Term Debt
331000
Quarters > 1 > balance Sheet > long Term Debt
28845000
Quarters > 1 > balance Sheet > total Liabilities
43126000
Quarters > 1 > balance Sheet > equity
19743000
Quarters > 1 > cash Flow > net Income
-5837000
Quarters > 1 > cash Flow > depreciation
626000
Quarters > 1 > cash Flow > change In Working Capital
197000
Quarters > 1 > cash Flow > cash From Operations
-2552000
Quarters > 1 > cash Flow > capital Expenditures
91000
Quarters > 1 > cash Flow > cash From Investing
-91000
Quarters > 1 > cash Flow > cash From Financing
31977000
Quarters > 1 > cash Flow > net Change In Cash
29334000
Quarters > 1 > ratios > PE
-0.20655874441159863
Quarters > 1 > ratios > PB
18.19191898647622
Quarters > 1 > ratios > ROE
-29.56490908169984
Quarters > 1 > ratios > ROA
-9.28438499101306
Quarters > 1 > ratios > FCF
-2643000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.2868149755832881
Quarters > 1 > health Score
13
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
8485000
Quarters > 2 > income Statement > cost Of Revenue
3353000
Quarters > 2 > income Statement > gross Profit
5132000
Quarters > 2 > income Statement > operating Expenses
11295000
Quarters > 2 > income Statement > operating Income
-6163000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-6008000
Quarters > 2 > income Statement > net Income
-6026000
Quarters > 2 > income Statement > eps
-0.21739665307282197
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
27718918
Quarters > 2 > income Statement > income Tax Expense
18000
Quarters > 2 > income Statement > EBITDA
-5829000
Quarters > 2 > income Statement > operating Margin
-72.63406010606953
Quarters > 2 > income Statement > total Other Income Expense Net
155000
Quarters > 2 > balance Sheet > cash
12387000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
3651000
Quarters > 2 > balance Sheet > inventories
6582000
Quarters > 2 > balance Sheet > total Current Assets
24214000
Quarters > 2 > balance Sheet > property Plant Equipment
5143000
Quarters > 2 > balance Sheet > total Assets
30070000
Quarters > 2 > balance Sheet > payables
1216000
Quarters > 2 > balance Sheet > short Term Debt
578000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
10083000
Quarters > 2 > balance Sheet > equity
19987000
Quarters > 2 > cash Flow > net Income
-6026000
Quarters > 2 > cash Flow > depreciation
334000
Quarters > 2 > cash Flow > change In Working Capital
-2605000
Quarters > 2 > cash Flow > cash From Operations
-6172000
Quarters > 2 > cash Flow > capital Expenditures
183000
Quarters > 2 > cash Flow > cash From Investing
-183000
Quarters > 2 > cash Flow > cash From Financing
-1362000
Quarters > 2 > cash Flow > net Change In Cash
-7717000
Quarters > 2 > ratios > PE
-0.21739665307282197
Quarters > 2 > ratios > PB
17.626829828388455
Quarters > 2 > ratios > ROE
-30.149597238204834
Quarters > 2 > ratios > ROA
-20.03990688393748
Quarters > 2 > ratios > FCF
-6355000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.7489687684148497
Quarters > 2 > health Score
22
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
7771000
Quarters > 3 > income Statement > cost Of Revenue
3009000
Quarters > 3 > income Statement > gross Profit
4762000
Quarters > 3 > income Statement > operating Expenses
10366000
Quarters > 3 > income Statement > operating Income
-5604000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-5386000
Quarters > 3 > income Statement > net Income
-5386000
Quarters > 3 > income Statement > eps
-0.19927709698630575
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
27027692
Quarters > 3 > income Statement > income Tax Expense
-430724
Quarters > 3 > income Statement > EBITDA
-5133000
Quarters > 3 > income Statement > operating Margin
-72.11427100759234
Quarters > 3 > income Statement > total Other Income Expense Net
218000
Quarters > 3 > balance Sheet > cash
20104000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
4713000
Quarters > 3 > balance Sheet > inventories
6863000
Quarters > 3 > balance Sheet > total Current Assets
33363000
Quarters > 3 > balance Sheet > property Plant Equipment
5091000
Quarters > 3 > balance Sheet > total Assets
39189000
Quarters > 3 > balance Sheet > payables
1340000
Quarters > 3 > balance Sheet > short Term Debt
557000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
13800000
Quarters > 3 > balance Sheet > equity
25389000
Quarters > 3 > cash Flow > net Income
-5386000
Quarters > 3 > cash Flow > depreciation
471000
Quarters > 3 > cash Flow > change In Working Capital
1758000
Quarters > 3 > cash Flow > cash From Operations
-1243000
Quarters > 3 > cash Flow > capital Expenditures
263000
Quarters > 3 > cash Flow > cash From Investing
-263000
Quarters > 3 > cash Flow > cash From Financing
37000
Quarters > 3 > cash Flow > net Change In Cash
-1469000
Quarters > 3 > ratios > PE
-0.19927709698630575
Quarters > 3 > ratios > PB
13.530346422466422
Quarters > 3 > ratios > ROE
-21.21391153649218
Quarters > 3 > ratios > ROA
-13.743652555564061
Quarters > 3 > ratios > FCF
-1506000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.19379745206537125
Quarters > 3 > health Score
23
Valuation > metrics > PE
-0.20722837622373264
Valuation > metrics > PB
22.761400122212425
Valuation > final Score
20
Valuation > verdict
658.7% Overvalued
Profitability > metrics > ROE
-37.110999118054686
Profitability > metrics > ROA
-11.476942858812757
Profitability > metrics > Net Margin
-0.6648233833653087
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.8022552601738693
Risk > metrics > Interest Coverage
-9.716390423572744
Risk > final Score
-21
Risk > verdict
High
Liquidity > metrics > Current Ratio
47.97102803738318
Liquidity > metrics > Quick Ratio
41.81869158878504
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-266
Prev Risks > 1
-90
Prev Risks > 2
-41
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T13:13:24.394Z
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AInvestment strategist names 10 sub-$10 billion stocks to watch in 2026 Finbold
Read more →Behavioral Patterns of CLPT and Institutional Flows news.stocktradersdaily.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$29
Analyst Picks
Strong Buy
2
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 40.31% of the total shares of Clearpoint Neuro Inc
1.
BlackRock Inc(6.1003%)
since
2025/06/30
2.
Vanguard Group Inc(5.1891%)
since
2025/06/30
3.
Vanguard Total Stock Mkt Idx Inv(2.8447%)
since
2025/07/31
4.
iShares Russell 2000 ETF(2.2429%)
since
2025/08/31
5.
Geode Capital Management, LLC(2.1979%)
since
2025/06/30
6.
Rolnik Focus FIL(1.7589%)
since
2025/08/31
7.
State Street Corp(1.1727%)
since
2025/06/30
8.
Morgan Stanley - Brokerage Accounts(1.169%)
since
2025/06/30
9.
Brown Advisory Holdings Inc(1.164%)
since
2025/06/30
10.
Essex Investment Management Company, LLC(1.1446%)
since
2025/06/30
11.
Vanguard Institutional Extnd Mkt Idx Tr(1.0448%)
since
2025/07/31
12.
D. E. Shaw & Co LP(1.0195%)
since
2025/06/30
13.
Goldman Sachs Group Inc(1.0089%)
since
2025/06/30
14.
Fidelity Small Cap Index(0.9185%)
since
2025/06/30
15.
Lane Generational LLC(0.9091%)
since
2025/06/30
16.
Financial Engines Advisors L.l.c.(0.8807%)
since
2025/06/30
17.
Cahill Wealth Management, LLC(0.8631%)
since
2025/03/31
18.
iShares Russell 2000 Growth ETF(0.802%)
since
2025/08/31
19.
Northern Trust Corp(0.7203%)
since
2025/06/30
20.
CM Management, LLC(0.7035%)
since
2025/06/30
21.
Taylor Frigon Capital Management LLC(0.6348%)
since
2025/06/30
22.
Conway Capital Management Inc(0.5777%)
since
2025/06/30
23.
UBS Group AG(0.5467%)
since
2025/06/30
24.
Parsons Capital Management Inc(0.5047%)
since
2025/06/30
25.
Fidelity Extended Market Index(0.5039%)
since
2025/07/31
26.
Vanguard Russell 2000 ETF(0.4357%)
since
2025/07/31
27.
Bank of America Corp(0.4%)
since
2025/06/30
28.
Millennium Management LLC(0.3513%)
since
2025/06/30
29.
State St Russell Sm Cap® Indx SL Cl I(0.3233%)
since
2025/08/31
30.
1290 Essex Small Cap Growth I(0.2587%)
since
2025/07/31
31.
Bridgeway Ultra-Small Company(0.2357%)
since
2025/06/30
32.
Schwab Small Cap Index(0.2306%)
since
2025/07/31
33.
NT R2000 Index Fund - NL(0.2217%)
since
2025/06/30
34.
iShares Micro-Cap ETF(0.2066%)
since
2025/08/31
35.
Extended Equity Market Fund K(0.192%)
since
2025/06/30
36.
NT R2000 Index Fund - DC - NL - 3(0.1767%)
since
2025/06/30
37.
Fidelity Total Market Index(0.1713%)
since
2025/07/31
38.
Taylor Frigon Core Growth(0.1645%)
since
2025/05/31
39.
Pleiades Small Cap Equity A(0.1639%)
since
2025/06/30
40.
iShares Russell 2000 Small-Cap Idx Instl(0.1588%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.